Department of Oncology, University of Tokyo, Tokyo, Japan
Commentary
From Biomarkers to Therapeutics: The Role of Cancer Metabolomics in Advancing Oncology Research
Author(s): Yuki Sato*
DOI:
10.37421/2153-0769.2024.14.386
Metabolomics:Open Access received 895 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 